Metabolically associated fatty liver disease – a disease of the 21st century: A review
Metabolically associated fatty liver disease (MAFLD) is a widespread chronic disease characterized by increased accumulation of fat in the liver, which is based on metabolic dysfunction. The incidence of MAFLD is well over 20% in most regions of the world and is on an increasing trend. Current think...
Main Authors: | Igor V. Maev, Dmitry N. Andreev, Yury A. Kucheryavyy |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ZAO "Consilium Medicum"
2022-07-01
|
Series: | Consilium Medicum |
Subjects: | |
Online Access: | https://consilium.orscience.ru/2075-1753/article/viewFile/112444/87265 |
Similar Items
-
ADEMETHIONINE IN THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: A. V. Polukhina, et al.
Published: (2017-11-01) -
Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01) -
Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
by: Wasitha P. D. W. Thilakarathna, et al.
Published: (2024-02-01) -
CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease
by: Ha Neul Kim, et al.
Published: (2023-03-01) -
Extracellular Vesicles as Drivers of Non-Alcoholic Fatty Liver Disease: Small Particles with Big Impact
by: David Højland Ipsen, et al.
Published: (2021-01-01)